Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
Safety of GW685698X (55 µg/day, q.d.) nasal spray over a period of 12 weeks in Japanese
paediatric subjects ages 2 to < 15 years with perennial allergic rhinitis will be evaluated.
And secondarily, efficacy and systemic exposure of GW685698X (55 µg/day, q.d.) nasal spray
over a period of 12 weeks in Japanese paediatric subjects ages 2 to < 15 years with perennial
allergic rhinitis will also be evaluated.